Yasir B. Al-wakeel - Net Worth and Insider Trading
Yasir B. Al-wakeel Net Worth
The estimated net worth of Yasir B. Al-wakeel is at least $318,448 dollars as of 2024-12-26. Yasir B. Al-wakeel is the CFO of Kronos Bio Inc and owns about 346,102 shares of Kronos Bio Inc (KRON) stock worth over $318,448. Details can be seen in Yasir B. Al-wakeel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yasir B. Al-wakeel has not made any transactions after 2023-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yasir B. Al-wakeel
Yasir B. Al-wakeel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yasir B. Al-wakeel owns 4 companies in total, including Kronos Bio Inc (KRON) , Neon Therapeutics Inc (NTGN) , and Merrimack Pharmaceuticals Inc (MACK) among others .
Click here to see the complete history of Yasir B. Al-wakeel’s form 4 insider trades.
Insider Ownership Summary of Yasir B. Al-wakeel
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRON | Kronos Bio Inc | 2023-07-06 | Chief Financial Officer |
NTGN | Neon Therapeutics Inc | 2020-05-06 | Chief Financial Officer |
MACK | Merrimack Pharmaceuticals Inc | 2015-08-11 | CFO and Head of Corp Dev |
2021-07-29 | director |
Yasir B. Al-wakeel Latest Holdings Summary
Yasir B. Al-wakeel currently owns a total of 1 stock. Yasir B. Al-wakeel owns 346,102 shares of Kronos Bio Inc (KRON) as of July 6, 2023, with a value of $318,448.
Latest Holdings of Yasir B. Al-wakeel
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRON | Kronos Bio Inc | 2023-07-06 | 346,102 | 0.92 | 318,448 |
Holding Weightings of Yasir B. Al-wakeel
Yasir B. Al-wakeel Form 4 Trading Tracker
According to the SEC Form 4 filings, Yasir B. Al-wakeel has made a total of 3 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Kronos Bio Inc is the sale of 9,617 shares on July 6, 2023, which brought Yasir B. Al-wakeel around $16,830.
Insider Trading History of Yasir B. Al-wakeel
- 1
Yasir B. Al-wakeel Trading Performance
GuruFocus tracks the stock performance after each of Yasir B. Al-wakeel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yasir B. Al-wakeel is 1.24%. GuruFocus also compares Yasir B. Al-wakeel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yasir B. Al-wakeel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yasir B. Al-wakeel's insider trading performs compared to the benchmark.
Performance of Yasir B. Al-wakeel
Yasir B. Al-wakeel Ownership Network
Yasir B. Al-wakeel Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Yasir B. Al-wakeel is the Chief Financial Officer of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Yasir B. Al-wakeel made 1 insider transaction in Kronos Bio Inc (KRON) with a net sale of 9,617. Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Yasir B. Al-wakeel Mailing Address
Above is the net worth, insider trading, and ownership report for Yasir B. Al-wakeel. You might contact Yasir B. Al-wakeel via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.